Optiscan Imaging Share Price and Company Fundamentals
Last traded: Today at 5:37 AM
Optiscan Imaging Limited engages in the development and commercialization of confocal endomicroscopic imaging technologies for medical, translational, and pre-clinical applications in Australia, North America, Europe, and Asia. It offers FIVE2 (ViewnVivo) system, a miniaturized fluorescence endomicroscope that brings imaging flexibility to preclinical research. The company also engages in the development of InVivage device for clinical use in the oral cancer and other cancer applications. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
|Primary activities||The research and development of a High Magnification Endoscope for clincial diagnosis and research; and the continuation of sales of the research grade benchtop confocal microscope system within Australia.|
|Industry / Sector||Scientific & Technical Instruments / Technology|
|Mailing address||16 Miles Street Mulgrave VIC 3170 Australia|
|Phone / Fax||61 3 9538 3333 / 61 3 9562 7742|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Optiscan Imaging does not pay dividends.
As of May 2021, following are the company executives and directors listed on Optiscan Imaging.
|Mr. Darren Lurie||MD & Director||315.17k|
|Mr. Justin Mouchacca C.A., B.Bus (Acc), CA||Company Sec.|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Optiscan Imaging is 240.02M and its enterprise value is 230.1M. The enterprise value to revenue ratio of OIL is 97.86.
The OIL's stocks Beta value is 2.12 making it 112% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Optiscan Imaging (OIL)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Optiscan Imaging (ASX:OIL) Frequently Asked Questions
1. What is Optiscan Imaging's Stock Symbol?
Optiscan Imaging trades on ASX under the ticker symbol "OIL".
2. What is Optiscan Imaging's stock price today?
One share of OIL stock can currently be purchased for approximately $0.39.
3. How can I contact Optiscan Imaging?
Optiscan Imaging's mailing address is 16 Miles Street Mulgrave VIC 3170 Australia. The company can be reached via phone at 61 3 9538 3333.
4. What is Optiscan Imaging's official website?
The official website of Optiscan Imaging is http://www.optiscan.com.
5. Which share registry manages Optiscan Imaging's stock?
Optiscan Imaging's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.